Predictability of Thromboelastography Parameters in Severe Post Partum Hemorrhage


The aim of the study is to determine if thromboelastography parameters can be predictive of severe post partum hemorrhage.

Full Title of Study: “Predictability of Thromboelastography Parameters in Severe Post Partum Hemorrhage : a Retrospective Study”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: July 2015


  • Diagnostic Test: thromboelastography
    • TEG5000® : Kaolin and Functional Fibrinogen tests on native blood sample

Arms, Groups and Cohorts

  • Post Partum Hemorrhage
    • Patients presenting with a post partum hemorrhage. A thromboelastography analysis is realized at discretion of the anesthesiologist in charge

Clinical Trial Outcome Measures

Primary Measures

  • Calculated blood loss
    • Time Frame: during the 24 hours after delivery
    • Calculated blood loss at 24 hours after delivery (Sum of the volume of blood transfused and the volume of blood loss calculated by the decrease in hematocrit.)

Participating in This Clinical Trial

Inclusion Criteria

  • Women presenting with a post partum hemorrhage
  • needing sulprostone infusion
  • during third trimester of pregnancy

Exclusion Criteria

  • known coagulation disorders

Gender Eligibility: Female

pregnant women

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Hôpital Armand Trousseau
  • Provider of Information About this Clinical Study
    • Principal Investigator: Pr Isabelle CONSTANT, Head of Anesthesiology Department – Hôpital Armand Trousseau
  • Overall Official(s)
    • Agnes Rigouzzo, MD, Study Director, Hôpital Armand Trousseau

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.